Where can I read KISSEI PHARMACEUTICAL Co., Ltd.'s disclosures in English?
Pulse News Wire translates all TDNet filings for KISSEI PHARMACEUTICAL Co., Ltd. (4547.T) to English. 7 disclosures have been translated since Jan 30, 2026.
How many disclosures has KISSEI PHARMACEUTICAL Co., Ltd. filed on TDNet?
Pulse News Wire has translated 7 disclosures for KISSEI PHARMACEUTICAL Co., Ltd. since Jan 30, 2026.
Does KISSEI PHARMACEUTICAL Co., Ltd. publish English IR materials?
No. KISSEI PHARMACEUTICAL Co., Ltd. is listed on the PRIME Market and has no English disclosure requirement. Pulse News Wire is the only English-language source for these filings.
What types of disclosures has KISSEI PHARMACEUTICAL Co., Ltd. filed?
KISSEI PHARMACEUTICAL Co., Ltd. has filed the following types of disclosures on TDNet: Earnings (4), Other (3).
English translations for all 4,449 JPX-listed companies.
Including the 2,300 Standard and Growth Market companies with no other English source.
